SLIM DISPLAY FOR
CAR-T OPTIMISATION
OXGENE’s proprietary CAR-T / antibody discovery platform targets challenging membrane proteins for the development of your CAR-T and other biologics. Antibody humanisation, affinity maturation and complex gene editing complete our discovery workflow.
